Nonviral prime editing: a delivery result in mouse liver

The assessment reports improved prime editing using lipid nanoparticles, including correction in a mouse phenylketonuria model. Delivery and RNA cargo design materially affected outcomes.

Compare in the Atlas

Concept illustration / not experimental evidence

What was reported

The assessment reports improved prime editing using lipid nanoparticles, including correction in a mouse phenylketonuria model. Delivery and RNA cargo design materially affected outcomes. [C14]

What the result does not establish

Performance in mouse liver is not a demonstration of delivery to every organ, and does not establish treatment of normal aging in people.

Measured endpoint

Prime-editing efficiency and disease-model correction.

Karam’s next question

Does the proposed target have a compatible sequence change, a plausible tissue route and an independent measure of benefit?

Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.

Record transparency

The details—and the missing values.

Extraction scope: supplied project assessment, not an independent full-methods extraction
Study date	2026-06-15
Reported region	United States
Species / biological system	Cells and mice
Target / subject	Disease-specific sequence targets
Cell or population context	Mouse liver, including a phenylketonuria model
Perturbation direction	Sequence correction
Method	Prime editing
Delivery setting	Lipid nanoparticles
Comparator	Not extracted in the supplied assessment; review the primary source before using this field.
Donor context	Not extracted in the supplied assessment; review the primary source before using this field.
Sample size / unit	Not extracted in the supplied assessment; review the primary source before using this field.
Follow-up	Not extracted in the supplied assessment; review the primary source before using this field.
Safety measurements	Not extracted in the supplied assessment; review the primary source before using this field.
Independent replication	Not established in the supplied assessment
Data access	Not extracted in the supplied assessment; review the primary source before using this field.

What would this evidence change?

Use the context in this record to define a bounded research or diligence question. A cited finding is not a validated Karam asset.

Discuss a scope Explore the Atlas